ea0031p328 | Steroids | SFEBES2013
Naredo-Gonzalez Gregorio
, Jansen Maurits
, Upreti Rita
, Semple Scott
, Merrifield Gavin
, Sutcliffe Oliver
, Hansen Michael
, Marshall Ian
, Andrew Ruth
, Walker Brian
Non-invasive methods to measure enzyme activity in vivo can provide a useful tool for the development of selective inhibitors. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), a reductase enzyme that amplifies active intracellular glucocorticoid levels, has been shown in obese patients using invasive tools (biopsy, microdialysis and arteriovenous sampling with stable isotope tracers). 11β-HSD1 inhibitors are efficacious in...